Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.08
Delayed Data
As of Dec 09
 -0.01 / -0.48%
Today’s Change
1.81
Today|||52-Week Range
5.15
-57.02%
Year-to-Date
3 Beaten-Up Biotech Stocks: Are They Bargains?
Dec 09 / MotleyFool.com - Paid Partner Content
3 Small-Cap Biotech Stocks That Could Double in 2017
Dec 02 / MotleyFool.com - Paid Partner Content
4 Small-Cap Stocks Worth Buying in 2017
Dec 07 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.09
Today’s open2.11
Day’s range2.06 - 2.23
Volume2,037,455
Average volume (3 months)1,704,741
Market cap$331.0M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,054.47%
P/E ratioNM
Price/Sales21.65
Price/Book2.32

Competitors

 Today’s
change
Today’s
% change
CGENCompugen Ltd+0.30+5.00%
EDGEEdge Therapeutics In...+0.08+0.68%
BTXBioTime Inc-0.07-2.06%
ONVOOrganovo Holdings In...+0.01+0.30%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$36.4M
Annual profit (last year)$46.0K
Net profit margin0.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs